-
Using data from the 2001-2002 National Health and Nutrition Examination Survey (NHANES), Selvin and colleagues analyzed the responses of men over 20 years of age about their experiences with erectile dysfunction (ED).
-
Using a large pharmacy data base, Irish investigators tracked Tamoxifen use and calculated prescription adherence. By 3.5 years after initial dose, approximately 1/3 of patients had discontinued use.
-
The FDA has approved aliskiren, the first of a new class of antihypertensive drugs, the oral renin inhibitors.
-
That there is a link between inflammation and atherosclerosis is no longer in dispute. Whether modulation of inflammation might change the process of atherosclerosis, or even better, reduce vascular endpoints, remains a challenging question.
-
Two recent large studies have looked at the effects of various inhaler combinations on outcomes in patients with COPD.
-
Regular napping in healthy people is associated with reduced coronary mortality, especially for working men.
-
In a family-based research cohort, men were followed for up to 40 years after the birth of their children, and those with only daughters had a 40% higher risk of prostate cancer compared with men with at least one son.
-
The first once-daily mesalamine formulation has been approved for the treatment of ulcerative colitis. The formulation uses the Multi Matrix System (MMX) technology designed to deliver the drug throughout the colon.
-
Non-narcotic analgesic use is associated with a moderate increase in hypertension in men. This association is greater with the use of non steroidal anti-inflammatory agents among obese and overweight men.
-
Immunochemical testing of stool for human blood appears to be a more sensitive and specific test for advanced colon neoplasia than current guaiac-based tests.
